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The Editorial on the Research Topic
Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases
Pathogenesis of many autoinflammatory and autoimmune diseases is largely driven by inap-
propriate or inadequate immune responses toward environmental challenges. Most of them 
are multifactorial. For example, assessment of disease risk factors in rheumatoid arthritis (RA) 
brings the share of genetic predisposition to 50–60%, with the rest attributed to environmental 
factors (1). Thus, the diseases such as RA are well defined by Meda et  al. (2) as comprising 
of both genetic and epigenetic components: “the disease of bad genes and bad luck.” While 
genetic predisposition to RA and other autoimmune and autoinflammatory diseases has been 
a subject of very extensive research in recent years, the role of environmental factors remains 
less explored. The research topic articles address the role of various environmental factors that 
may contribute to the onset of autoinflammatory and autoimmune disorders. They are presented 
in the following order: purely environmental factors, dysbiotic conditions, and infections of 
bacterial, fungal, and viral nature.
In their comprehensive review, Anaya et al. discuss what they call the “autoimmune ecology,” 
which  includes all levels involved, from the ecosphere to the environmental factors and to the 
molecular mechanisms of interaction of these factors with the human immune system. The role of 
microbiota and vaccines, lifestyle habits and socioeconomic status, organic solvents, ultraviolet, and 
other factors is discussed in the context of how these factors may interact with the innate immunity 
via the toll-like receptor signaling pathway, B-cell activation, the T helper 17, and regulatory T 
(Treg) cells, posttranslational modifications of self-antigens, and epigenetic modifications. This is 
a formidable attempt to synthetize the current knowledge of how various environmental factors 
(collectively called exposome) may interact with the immune system leading to differential outcomes 
including autoimmune disease.
In the perspective article by Pollard, the silica-induced trigger mechanisms in the pathogenesis 
of inflammatory and autoimmune diseases are overviewed. Despite the proven epidemiological 
link between the silica exposure and autoimmune diseases, very little is known about the mecha-
nistic factors leading to this disease. Based on currently available human and animal studies, a 
putative chain of events is proposed, which begins with activation of the innate immune system 
and then leads to proinflammatory cytokine production, pulmonary inflammation, activation of 
adaptive immunity, breaking of tolerance, autoantibody production, and tissue damage. Animal 
models of the silica exposure, which are used to mimic human autoimmunity, are also discussed.
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In systemic lupus erythematosus (SLE), with the disease onset 
in adulthood, the preceding prenatal/maternal history could bear 
important risk factors (Parks et  al.). The authors demonstrate 
specific links between SLE and some early-life factors such as 
preterm birth, low birth weight, early prenatal/maternal farm 
exposure, and extended farm residence in childhood.
Several articles highlight a potential link between autoim-
mune diseases and the gastrointestinal tract disorders such as 
dysbiosis and bacterial infections. A review article by Ignacio 
et  al. overviews host–microbe interaction and how the innate 
immune system senses gut microbiota and their metabolites 
via the inflammasomes and toll-like receptors. Disturbances in 
this fine-tuned cross talk may cause inappropriate modulations 
of inflammatory pathways thus leading to local and systemic 
inflammatory and autoimmune diseases.
In their hypothesis and theory article Lerner et  al. propose 
an interesting mechanism, which may explain why a dysbiotic 
microbiota may have a potential role in autoimmune diseases. 
Physiologically normal posttranslational modifications of proteins 
by gut microbiota include cross-linking, de/amination/deamida-
tion, de/phosphorylation, a/deacetylation, de/tyrosination, de/
glutamylation, de/glycylation, ubiquitination, palmitoylation, 
glycosylation, galactosylation, arginylation, methylation, citrul-
lination, sumoylation, carbamylation, and others. The balance of 
these activities in dysbiosis may be compromised thus generating 
highly immunogenic or neo-epitopes, which may break the toler-
ance and induce autoimmunity.
In the opinion article by Saxena, probiotic treatment is 
proposed as an alternative to the conventional treatment of 
Guillain–Barré syndrome, an immune-mediated peripheral 
neuropathy. The main idea is that probiotics may help to normal-
ize the dysbiotic microbiota and replenish Treg cells to promote 
immune homeostasis.
Regarding gastrointestinal infections, Khaiboullina et al. dem-
onstrate that gastroduodenitis caused by Helicobacter pylori is due 
to the upregulation of serum chemokines CXCL5 and CXCL6. 
This may lead to the local neutrophil accumulation at the sites of 
inflammation. H. pylori can also be protective against allergy and 
asthma, and Hussain et al. demonstrate a potential link between 
the human systemic type 1 T helper and Treg responses to H. 
pylori and allergen-specific IgE levels. The conclusion is that the 
systemic IL-10+ Treg response is likely to play a role in H. pylori-
mediated protection against allergy in humans.
Chronic infections of the upper gastrointestinal tract can also 
provoke autoimmune conditions. Fuggle et al. performed exten-
sive meta-analysis of data extracted from relevant publications to 
elucidate a potential link between RA and periodontitis. There 
is indeed a significant association between these two conditions. 
However, when we compare RA and osteoarthritis as a control, 
there is no significant difference in the prevalence of periodontitis 
in these two groups.
Some viral infections are the potent inducers of immune 
response, while others such as hantavirus infection are con-
sidered as having a much lesser impact. However, Morzunov 
et  al. demonstrate a differential expression of serum cytokines 
involved in migration of lymphocytes, natural killer cells, and 
dendritic cells to the sites of hantavirus infection. There is also a 
significant upregulation of cytokines regulating leukocyte migra-
tion, repair of lung tissue, permeability of endothelial monolayer, 
and transendothelial leukocyte migration. On the contrary, 
cytokines associated with the platelet numbers and functions 
are downregulated. The same research group also reviews the 
hantaviral proteins and their potential involvement in hantavirus 
infection (Muyangwa et al.).
Another article from the same group (Boichuk et al.) shows 
the loss of plasmacytoid dendritic cells (pDCs), which are the 
major producers of interferon (IFN) type I, in the periphery of 
subjects with HIV/AIDS. This is presumably due to the decrease 
in serum cytokines. At the same time, gut-associated pDCs in HIV 
express the cellular proliferation marker Ki-67 suggesting that 
gut-associated pDCs are naive and possibly of the bone marrow 
origin. Gut-associated pDCs display activated phenotypes, with 
the elevated level of the proapoptotic enzyme, granzyme B. These 
data support a model of HIV progression where the peripheral 
pDCs are depleted and replaced by naive bone marrow-derived 
pDCs with limited IFN-producing capabilities. Ultimately, these 
pDCs migrate to the gut, with a potential impact on the gut 
mucosa due to the production of inflammatory cytokines and 
granzyme B.
Attempts to develop novel treatments against viral diseases 
such as swine flu, which is caused by the subtype of influenza A 
virus (H1N1), include the exploration of potentials of traditional 
medicine (Romero-Pérez et al.). The authors demonstrate some 
positive effects of stems and roots of Salacia reticulate (used in 
traditional Indian medicine Ayurveda) in a mouse model of 
H1N1 infection. These effects are presumably due to the increased 
natural killer cell activity in the host.
A potential role of common microbial and viral infections in 
the onset of RA is reviewed by Arleevskaya et al. The authors con-
clude that the optimal immune response toward these infections 
could be achieved via its reasonable adequacy and fine balance 
of immune system components. In some patients, however, this 
delicate equilibrium is compromised thus leading to the onset 
of RA. Contributing factors among these patients could be (i) 
higher susceptibility to bacterial and viral infections; (ii) greater 
imbalance of immune system components; (iii) limited capabil-
ity to control and resolve inflammation; and (iv) compromised 
interaction at the microorganism–immune system interface. 
Thus, the disease onset is driven by the combination of genetic 
and environmental factors.
An important event in launching an appropriate immune 
response is sensing the invading pathogens by the innate 
immune system, and one of the important components of 
it is a protein called pyrin. Manukyan and Aminov give an 
up-to-date review of structure and function of this protein. 
They also examined molecular mechanisms of pathogenesis 
of familial Mediterranean fever, one of the most common 
hereditary autoinflammatory syndromes caused by mutations 
in pyrin. The high carrier frequency found in the affected 
populations from the Mediterranean Basin suggests a selec-
tive advantage conferred by the heterozygous state such as 
protection against presumptive pathogen(s). Identity of the 
suspected pathogen(s) that had selected for this genetic trait, 
however, remains elusive.
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Another sensing molecule brought up in this topic is 
pentraxin-3, which serves as a key soluble pattern recognition 
receptor as well as interacts with the components of complement 
pathway. Hence, it plays an important role in innate immune 
responses against several bacterial, fungal, and viral infections. 
Computational analysis of non-synonymous single nucleotide 
polymorphisms (nsSNPs) in the PTX-3 gene suggests that 
there are 10 high-risk nsSNPs (Thakur and Shankar). Four of 
them affect the conserved structural and functional residues in 
the pentraxin-domain thus compromising interaction with the 
C1q component of complement pathway. This may result in an 
increased susceptibility to infections among the carriers of these 
nsSNPs.
SNP-associated risk factors are not necessarily limited to 
structural/regulatory proteins involved in pathogen sensing, sig-
nal transduction, or immune response. An in silico analysis of 72 
SNPs associated with 43 primary Sjögren’s syndrome (SS) genetic 
risk factors suggests that only 5.6% are associated with the coding 
sequences (Konsta et al.). Other SNPs include intron sequences 
(55.6%), regions upstream/downstream of genes (30.5%), and 
intergenic regions (8.3%). Consequently, a significant enrichment 
by regulatory motifs (promoter, enhancer, insulator, DNAse peak, 
and expression quantitative trait loci) characterizes risk variants 
for SS (94.4%). Analysis of risk variants for SS among histone 
markers in B  cells, monocytes, and epithelial cells shows their 
close association with promoters and enhancers in B  cells and 
with enhancers in monocytes.
In conclusion, articles in this research topic made a very 
significant contribution to our understanding of the role played 
by environmental factors, dysbiotic conditions, and infections 
in triggering autoimmune and autoinflammatory diseases. Since 
this is a rapidly expanding area of research, many other factors 
contributing to the onset of these diseases are not covered here. 
We are confident, however, that further studies will expand 
the list as well as bring a better understanding of mechanisms 
involved in the onset of autoimmune and autoinflammatory 
diseases.
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